AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 132.66 Increased By ▲ 3.13 (2.42%)
BOP 6.89 Increased By ▲ 0.21 (3.14%)
CNERGY 4.57 Decreased By ▼ -0.06 (-1.3%)
DCL 8.92 Decreased By ▼ -0.02 (-0.22%)
DFML 42.75 Increased By ▲ 1.06 (2.54%)
DGKC 84.00 Increased By ▲ 0.23 (0.27%)
FCCL 32.90 Increased By ▲ 0.13 (0.4%)
FFBL 77.06 Increased By ▲ 1.59 (2.11%)
FFL 12.20 Increased By ▲ 0.73 (6.36%)
HUBC 110.01 Decreased By ▼ -0.54 (-0.49%)
HUMNL 14.40 Decreased By ▼ -0.16 (-1.1%)
KEL 5.53 Increased By ▲ 0.14 (2.6%)
KOSM 8.32 Decreased By ▼ -0.08 (-0.95%)
MLCF 39.67 Decreased By ▼ -0.12 (-0.3%)
NBP 65.50 Increased By ▲ 5.21 (8.64%)
OGDC 198.74 Decreased By ▼ -0.92 (-0.46%)
PAEL 26.00 Decreased By ▼ -0.65 (-2.44%)
PIBTL 7.62 Decreased By ▼ -0.04 (-0.52%)
PPL 159.00 Increased By ▲ 1.08 (0.68%)
PRL 26.24 Decreased By ▼ -0.49 (-1.83%)
PTC 18.35 Decreased By ▼ -0.11 (-0.6%)
SEARL 82.24 Decreased By ▼ -0.20 (-0.24%)
TELE 8.12 Decreased By ▼ -0.19 (-2.29%)
TOMCL 34.40 Decreased By ▼ -0.11 (-0.32%)
TPLP 8.98 Decreased By ▼ -0.08 (-0.88%)
TREET 16.88 Decreased By ▼ -0.59 (-3.38%)
TRG 59.49 Decreased By ▼ -1.83 (-2.98%)
UNITY 27.52 Increased By ▲ 0.09 (0.33%)
WTL 1.40 Increased By ▲ 0.02 (1.45%)
BR100 10,614 Increased By 206.9 (1.99%)
BR30 31,874 Increased By 160.5 (0.51%)
KSE100 98,972 Increased By 1644 (1.69%)
KSE30 30,784 Increased By 591.7 (1.96%)
World

U.S. Vice President Pence says Moderna's COVID-19 vaccine could be approved Friday

  • A panel of outside FDA advisers met to discuss Moderna's vaccine on Thursday and an agency decision on its emergency use authorization was expected as soon as Friday.
Published December 18, 2020

U.S. Vice President Mike Pence said the U.S. approval for Moderna Inc's coronavirus vaccine could come within hours later on Friday, after President Donald Trump tweeted that the vaccine had been approved.

The U.S. Food and Drug Administration has made no public announcement yet regarding its decision, and redirected Reuters to its statement from Thursday that the agency was working to rapidly authorize the vaccine.

Moderna did not immediately respond to a request for comment.

A panel of outside FDA advisers met to discuss Moderna's vaccine on Thursday and an agency decision on its emergency use authorization was expected as soon as Friday.

The panel had endorsed its use with a 20-0 vote, and one abstention, that the vaccine's benefits outweighed its risks.

The FDA, in a first, authorized Pfizer Inc's coronavirus vaccine earlier this month.

Pence received Pfizer's COVID-19 vaccine at a White House event on Friday and President elect Joe Biden is expected to get the shot next week in an effort to boost confidence in the safety of the vaccine, which will become widely available to the public next year.

Comments

Comments are closed.